ClinicalTrials.Veeva

Menu

Multiple Myeloma Turkish Prospective Patient Registry (THD-MM-Reg)

T

Turkish Hematology Association

Status

Enrolling

Conditions

Relapse Multiple Myeloma
Multiple Myeloma

Study type

Observational

Funder types

Other

Identifiers

NCT04143932
THD-MM-Reg

Details and patient eligibility

About

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

Full description

In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end.

All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed as multiple myeloma
  • Patients signed informed consent form
  • Patients received no more then 2 lines of therapy

Exclusion criteria

  • Patients below 18 years old

Trial contacts and locations

1

Loading...

Central trial contact

Ilker Kurkcu, Pharm; Omur Gokmen Sevindik, Assoc. Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems